Baqiyatallah University of Medical Sciences is a public and special medical university in Tehran, Iran. The BMSU was founded in 1994 as the primary medical institution for the Islamic Revolutionary Guard Corps.

During the past decade, Baqiyatallah Medical Sciences University conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Baqiyatallah Medical Sciences University" are "Acute Obliterating Bronchiolitis" (2 trials) and "Bronchiolitis Obliterans" (2 trials). Many other conditions were trialed in "Baqiyatallah Medical Sciences University" in a lesser frequency.

Most popular intervention types in "Baqiyatallah Medical Sciences University" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Clarithromycin" (1 trials) and "Erythromycin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Baqiyatallah Medical Sciences University" are 2 trials for "Male" genders.

Currently, there are NaN active trials in "Baqiyatallah Medical Sciences University". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Baqiyatallah Medical Sciences University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Baqiyatallah Medical Sciences University, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".